Using biomarkers to predict treatment response in major depressive disorder: evidence from past and present studies
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Major depressive disorder (MDD) is a heterogeneous condition with a variable response to a wide range of treatments. Despite intensive efforts, no biomarker has been identified to date that can reliably predict response or non-response to any form of treatment, nor has one been identified that can be used to identify those at high risk of developing treatment-resistant depression (ie, non-response to a sequence of treatments delivered for adequate duration and intensity). This manuscript reviews some past areas of research that have proved informative, such as studies using indexes of hypercortisolism or sleep disturbance, and more recent research findings using measures of inflammation and different indicators of regional cortical activation to predict treatment response. It is concluded that, although no method has yet been demonstrated to be sufficiently accurate to be applied in clinical practice, progress has been made. It thus seems likely that--at some point in the not-too-distant future--it will be possible to prospectively identify, at least for some MDD patients, the likelihood of response or non-response to cognitive therapy or various antidepressant medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“peripheral inflammatory mediators have emerged as promising candidate biomarkers for MDD (13)”
From Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies (2017) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617
Sleep and Psychiatric Disorders: A Meta-analysis
Benca, R. M. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080059010 · Cited by 1,468
Miller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
McGrath, C. L., Kelley, M. E., Holtzheimer, P. E., Dunlop, B. W., Craighead, W. E., Franco, A. R., Craddock, R. C., & Mayberg, H. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.143 · Cited by 561
Use of fMRI to Predict Recovery From Unipolar Depression With Cognitive Behavior Therapy
Siegle, G. J., Carter, C. S., & Thase, M. E. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.735 · Cited by 495
Self-citationKessler, R. C., Merikangas, K. R., & Wang, P. S. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091444 · Cited by 468
Stuck in a rut: rethinking depression and its treatment
Holtzheimer, P. E., & Mayberg, H. S. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2010.10.004 · Cited by 430
Kennedy, S. H., Konarski, J. Z., Segal, Z. V., Lau, M. A., Bieling, P. J., McIntyre, R. S., & Mayberg, H. S. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.5.778 · Cited by 420
Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.14010094 · Cited by 418
Downar, J., Geraci, J., Salomons, T. V., Dunlop, K., Wheeler, S., McAndrews, M. P., Bakker, N., Blumberger, D. M., Daskalakis, Z. J., Kennedy, S. H., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.10.026 · Cited by 337
The DST as a predictor of outcome in depression: a meta-analysis
Ribeiro, S. C. M., Tandon, R., Grunhaus, L., & Greden, J. F. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1618 · Cited by 329
Trivedi, M. H., McGrath, P. J., Fava, M., Parsey, R. V., Kurian, B. T., Phillips, M. L., Oquendo, M. A., Bruder, G., Pizzagalli, D., Toups, M., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.03.001 · Cited by 286
Fales, C. L., Barch, D. M., Rundle, M. M., Mintun, M. A., Mathews, J., Snyder, A. Z., & Sheline, Y. I. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.027 · Cited by 266
GENDEP Investigators, MARS Investigators, STAR*D Investigators, Uher, R., Tansey, K. E., Henigsberg, N., Wolfgang, M., Mors, O., Hauser, J., Placentino, A., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12020237 · Cited by 244
Siegle, G. J., Thompson, W. K., Collier, A., Berman, S. R., Feldmiller, J., Thase, M. E., & Friedman, E. S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.65 · Cited by 208
Self-citationCarvalho, L. A., Torre, J. P., Papadopoulos, A. S., Poon, L., Juruena, M. F., Markopoulou, K., Cleare, A. J., & Pariante, C. M. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.036 · Cited by 167
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.502 · Cited by 157
Self-citationThase, M. E. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020013003 · Cited by 142
Self-citationPapakostas, G. I., Shelton, R. C., Zajecka, J. M., Bottiglieri, T., Roffman, J., Cassiello, C., Stahl, S. M., & Fava, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08947 · Cited by 139
The STAR*D Trial: Revealing the Need for Better Treatments
Insel, T. R., & Wang, P. S. (2009) · Psychiatric Services · doi:10.1176/ps.2009.60.11.1466 · Cited by 131
Efficacy markers in depression
Harmer, C. J., Cowen, P. J., & Goodwin, G. M. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110367722 · Cited by 122
Electroencephalographic Sleep Profiles Before and After Cognitive Behavior Therapy of Depression
Thase, M. E., Fasiczka, A. L., Berman, S. R., Simons, A. D., & Reynolds, C. F. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.2.138 · Cited by 118
Self-citationLobello, K. W., Preskorn, S. H., Guico-Pabia, C. J., Jiang, Q., Paul, J., Nichols, A. I., Patroneva, A., & Ninan, P. T. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04773blu · Cited by 109
Siegle, G. J., Steinhauer, S. R., Friedman, E. S., Thompson, W. S., & Thase, M. E. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.041 · Cited by 107
Self-citationPajer, K., Andrus, B. M., Gardner, W., Lourie, A., Strange, B., Campo, J., Bridge, J., Blizinsky, K., Dennis, K., Vedell, P., et al. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.26 · Cited by 105
Owens, M., Herbert, J., Jones, P. B., Sahakian, B. J., Wilkinson, P. O., Dunn, V. J., Croudace, T. J., & Goodyer, I. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318786111 · Cited by 101
Redei, E. E., Andrus, B. M., Kwasny, M. J., Seok, J., Cai, X., Ho, J., & Mohr, D. C. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.66 · Cited by 83
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.7.886 · Cited by 80
Self-citationThase, M. E., Kupfer, D. J., Fasiczka, A. L., Buysse, D. J., Simons, A. D., & Frank, E. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00259-4 · Cited by 79
Self-citationQuest for biomarkers of treatment-resistant depression: Shifting the paradigm toward risk
Smith, D. F. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00057 · Cited by 22
Research works printed but not linked: 2
- Thase ME. Howland R. Biological processes in depression: updated review and integration. In: Beckham EE, Leber WR, eds. Handbook of Depression. New York, NY: Guilford Press. 1995 213 279
- Thase ME. Kupfer DJ. Current status of EEG sleep in the assessment and treatment of depression. In: Burrows GD, Werry JW, eds. Advances in Human Psychopharmacology. Volume 4. Greenwich, CT: JAI Press, Inc. 1987 93 148
Cited by
Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies
Köhler, C. A., Freitas, T. H., Maes, M., de Andrade, N. Q., Liu, C. S., Fernandes, B. S., Stubbs, B., Solmi, M., Veronese, N., Herrmann, N., et al. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12698 · Cited by 1,443
“Perhaps as a consequence of this, peripheral inflammatory mediators have emerged as promising candidate biomarkers for MDD (13), although evidence of bias may limit inferences derived from the literature on peripheral biomarkers for MDD (14).”
BackgroundBiomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415
“Biomarkers: systems and sources Biomarkers provide a potential target for identifying predictors of response to various interventions.(19) The evidence to date suggests that markers reflecting the activity of inflammatory, neurotransmitter, neurotrophic, neuroendocrine and metabolic systems may be able to predict ment…”
BackgroundPerlman, K., Benrimoh, D., Israel, S., Rollins, C., Brown, E., Tunteng, J.-F., You, R., You, E., Tanguay-Sela, M., Snook, E., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.067 · Cited by 182
Studying depression using imaging and machine learning methods
Patel, M. J., Khalaf, A., & Aizenstein, H. J. (2016) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.11.003 · Cited by 178
“Additionally, non-imaging measures have also been studied as potential biomarkers for depression and its treatment response (Lopresti et al., 2014; Thase, 2014).”
Oluboka, O. J., Katzman, M. A., Habert, J., McIntosh, D., MacQueen, G. M., Milev, R. V., McIntyre, R. S., & Blier, P. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx081 · Cited by 104
“…have yet to demonstrate a positive impact on health outcomes in clinical practice; however, future research may eventually prove biomarkers to be beneficial in selecting appropriate antidepressants in specific patient populations (Dunlop and Mayberg, 2014; Leuchter et al., 2014; Thase, 2014a).”
BackgroundMethod
Metadata
- Authors
- Thase, M. E.
- Affiliations
- Philadelphia VA Medical Center (US)
- Corresponding author
- Thase, Michael E.
- ORCID
- Thase, Michael E.
- Venue
- Dialogues in Clinical Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2014-12-31
- Volume
- 16
- Issue
- 4
- Pages
- 539-544
- ISSN
- 1294-8322 (ISSN-L)
- 1958-5969
- PMC
- PMC4336922
- OpenAlex
- W2398143306
- Cited by
- 57
- References
- 30
- Citations by year
- 2025: 3 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 7 · 2017: 14 · 2016: 5 · 2015: 1
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Dialogues in Clinical Neuroscience (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- major depressive disorder, treatment response prediction, biomarkers, treatment-resistant depression, hypercortisolism, sleep disorders, inflammation, cortical activation, antidepressant response, cognitive therapy
- MeSH terms
- Antidepressive Agents, Major Depressive Disorder, Humans, Biomarkers, Cognitive Behavioral Therapy, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.